Perspective Therapeutics(CATX)
$0.83+0.04 (+4.96%)
CATX
Perspective Therapeutics financials statements
$0.83
At close:+0.04 (+4.96%)
Want to see CATX full AI Analyst Report?
Perspective Therapeutics (CATX) Ratios
1,693 Followers
Perspective Therapeutics Ratios
CATX's free cash flow for Q3 2026 was $-35.89M. For the 2026 fiscal year, CATX's free cash flow was decreased by $-4.54M and operating cash flow was $-31.35M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.17 | 12.68 | 1.07 | 19.89 | 34.47 |
| Quick Ratio | 5.17 | 12.68 | 1.07 | 19.36 | 33.89 |
| Cash Ratio | 1.07 | 3.38 | 0.59 | 7.84 | 32.71 |
| Solvency Ratio | -1.67 | -1.53 | -2.00 | -4.15 | -2.41 |
| Operating Cash Flow Ratio | -2.88 | -1.00 | -2.36 | -4.55 | -4.18 |
| Short-Term Operating Cash Flow Coverage | -1472.93 | -351.81 | -753.33 | 0.00 | 0.00 |
| Net Current Asset Value | $ 88.45M | $ 180.73M | $ -5.88M | $ 49.77M | $ 60.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.03 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.02 | 0.01 | 0.03 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.02 | 0.01 | 0.03 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.29 | 1.17 | 1.30 | 1.06 | 1.04 |
| Debt Service Coverage Ratio | -231.50 | 3139.00 | -280.52 | 0.00 | -61.11 |
| Interest Coverage Ratio | -302.03 | -217.90 | -487.39 | 0.00 | -62.11 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.06 | 0.05 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.27 | -5.50 | 0.17 | 1.41 | 8.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -58.60% | 100.00% | 23.00% | 42.76% |
| EBIT Margin | 0.00% | -5600.00% | -2855.02% | -213.71% | 0.00% |
| EBITDA Margin | 0.00% | 719.33% | -2786.61% | -208.87% | -68.47% |
| Operating Profit Margin | 0.00% | 719.33% | -2855.02% | -213.71% | -68.47% |
| Pretax Profit Margin | 0.00% | -5596.70% | -2796.79% | -206.50% | -67.36% |
| Net Profit Margin | 0.00% | -5452.48% | -3243.24% | -206.50% | -66.26% |
| Continuous Operations Profit Margin | 0.00% | -5531.43% | -2611.92% | -206.50% | -66.26% |
| Net Income Per EBT | 98.75% | 97.42% | 115.96% | 100.00% | 98.36% |
| EBT Per EBIT | 91.96% | -778.05% | 97.96% | 96.63% | 98.39% |
| Return on Assets (ROA) | -38.63% | -23.24% | -47.51% | -25.25% | -10.64% |
| Return on Equity (ROE) | -49.81% | -27.27% | -61.86% | -26.85% | -11.11% |
| Return on Capital Employed (ROCE) | -47.66% | 3.24% | -49.79% | -27.40% | -11.30% |
| Return on Invested Capital (ROIC) | -47.16% | 3.15% | -46.45% | -28.73% | -11.07% |
| Return on Tangible Assets | -45.43% | -27.23% | -198.12% | -25.29% | -10.65% |
| Earnings Yield | -50.80% | -38.58% | -21.07% | -10.82% | -4.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 12.53 | 1.22 | 5.21 | 6.55 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 3.55 | 7.30 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 3.88 | 5.79 |
| Fixed Asset Turnover | 0.00 | 0.02 | 0.23 | 3.45 | 4.13 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.12 | 0.16 |
| Working Capital Turnover Ratio | 0.00 | 0.01 | 0.06 | 0.13 | 0.30 |
| Cash Conversion Cycle | 0.00 | 29.12 | 299.08 | 61.22 | 68.74 |
| Days of Sales Outstanding | 0.00 | 29.12 | 299.08 | 70.03 | 55.69 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 94.02 | 63.09 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 102.83 | 50.03 |
| Operating Cycle | 0.00 | 29.12 | 299.08 | 164.05 | 118.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.12 | -0.28 | -0.67 | -0.22 | -0.14 |
| Free Cash Flow Per Share | -1.29 | -1.13 | -0.69 | -0.23 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | -6.47 | -0.34 | -34.43 | -40.30 | -28.98 |
| Capital Expenditure Coverage Ratio | -6.47 | -0.34 | -34.43 | -40.30 | -28.98 |
| Operating Cash Flow Coverage Ratio | -25.36 | -4.50 | -14.47 | 0.00 | -11.83 |
| Operating Cash Flow to Sales Ratio | 0.00 | -12.58 | -25.74 | -1.71 | -0.71 |
| Free Cash Flow Yield | -46.92% | -35.38% | -17.21% | -9.20% | -4.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.96 | -2.59 | -4.75 | -9.24 | -23.72 |
| Price-to-Sales (P/S) Ratio | 0.00 | 141.35 | 153.92 | 19.09 | 15.72 |
| Price-to-Book (P/B) Ratio | 0.98 | 0.71 | 2.94 | 2.48 | 2.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.13 | -2.83 | -5.81 | -10.87 | -21.27 |
| Price-to-Operating Cash Flow Ratio | -2.46 | -11.23 | -5.98 | -11.14 | -22.00 |
| Price-to-Earnings Growth (PEG) Ratio | -0.14 | -0.06 | -0.02 | -0.09 | -0.19 |
| Enterprise Value Multiple | -1.74 | 14.15 | -5.36 | -7.73 | -14.88 |
| Enterprise Value | 175.61M | 148.00M | 214.03M | 114.62M | 109.96M |
| EV to EBITDA | -1.74 | 14.15 | -5.36 | -7.73 | -14.88 |
| EV to Sales | 0.00 | 101.79 | 149.26 | 16.14 | 10.19 |
| EV to Free Cash Flow | -1.84 | -2.04 | -5.63 | -9.19 | -13.79 |
| EV to Operating Cash Flow | -2.13 | -8.09 | -5.80 | -9.42 | -14.26 |
| Tangible Book Value Per Share | 2.26 | 3.74 | 0.01 | 0.99 | 1.17 |
| Shareholders’ Equity Per Share | 2.80 | 4.51 | 1.37 | 1.00 | 1.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.03 | 0.07 | 0.00 | 0.02 |
| Revenue Per Share | 0.00 | 0.02 | 0.03 | 0.13 | 0.20 |
| Net Income Per Share | -1.40 | -1.23 | -0.85 | -0.27 | -0.13 |
| Tax Burden | 0.99 | 0.97 | 1.16 | 1.00 | 0.98 |
| Interest Burden | 1.00 | 1.00 | 0.98 | 0.97 | 0.00 |
| Research & Development to Revenue | 0.00 | 28.64 | 14.86 | 0.37 | 0.24 |
| SG&A to Revenue | 0.00 | 18.30 | 14.62 | 1.53 | 0.61 |
| Stock-Based Compensation to Revenue | 0.00 | 3.70 | 2.61 | 0.19 | 0.10 |
| Income Quality | 0.80 | 0.23 | 0.79 | 0.83 | 1.06 |
Currency in USD
